Elizabeth McKee Anderson's most recent trade in GSK Plc - ADR was a trade of 392 Ords 0.31p done at an average price of $25.9 . Disclosure was reported to the exchange on March 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 25.90 per share. | 20 Mar 2026 | 392 | 6,854 (0%) | 0% | 25.9 | 10,152 | Ords 0.31p |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2026 | 15,000 | 8,215 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2026 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 24.28 per share. | 19 Dec 2025 | 402 | 6,412 (0%) | 0% | 24.3 | 9,760 | Ords 0.31p |
| Insmed Inc | Elizabeth McKee Anderson | Director | Sale of securities on an exchange or to another person at price $ 204.58 per share. | 24 Nov 2025 | 5,000 | 58,729 (0%) | 0% | 204.6 | 1,022,900 | Common Stock |
| Insmed Inc | Elizabeth McKee Anderson | Director | Sale of securities on an exchange or to another person at price $ 195.87 per share. | 14 Nov 2025 | 10,000 | 63,729 (0%) | 0% | 195.9 | 1,958,700 | Common Stock |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 21.87 per share. | 10 Oct 2025 | 52 | 6,010 (0%) | 0% | 21.9 | 1,137 | Ords 0.31p |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.37 per share. | 19 Sep 2025 | 480 | 5,958 (0%) | 0% | 20.4 | 9,777 | Ords 0.31p |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.28 per share. | 10 Jul 2025 | 54 | 5,478 (0%) | 0% | 19.3 | 1,041 | Ords 0.31p |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 11,574 | 11,574 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 3,142 | 23,215 (0%) | 0% | 0 | Common Stock | |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 18.95 per share. | 20 Jun 2025 | 516 | 5,424 (0%) | 0% | 18.9 | 9,777 | Ords 0.31p |
| Biomarin pharma Inc - Registered Shares | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 6,650 | 34,450 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,058 | 73,729 (0%) | 0% | - | Common Stock | |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 17.06 per share. | 11 Apr 2025 | 52 | 4,908 (0%) | 0% | 17.1 | 887 | Ords 0.31p |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 19.64 per share. | 20 Mar 2025 | 496 | 4,856 (0%) | 0% | 19.6 | 9,740 | Ords 0.31p |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Sale or transfer of securities back to the company at price $ 16.67 per share. | 10 Jan 2025 | 42 | 4,360 (0%) | 0% | 16.7 | 700 | Ords 0.31p |
| GSK PLC (ADR) | McKee Elizabeth Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 16.90 per share. | 20 Dec 2024 | 544 | 4,318 (0%) | 0% | 16.9 | 9,196 | Ords 0.31p |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.53 per share. | 11 Oct 2024 | 32 | 3,774 (0%) | 0% | 19.5 | 625 | Ords 0.31p |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.51 per share. | 23 Sep 2024 | 446 | 3,742 (0%) | 0% | 20.5 | 9,146 | Ords 0.31p |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.68 per share. | 12 Jul 2024 | 28 | 3,296 (0%) | 0% | 19.7 | 551 | Ords 0.31p |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 16,700 | 16,700 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 15,955 | 15,955 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,800 | 20,625 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,248 | 20,073 (0%) | 0% | 0 | Common Stock | |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.38 per share. | 20 Jun 2024 | 450 | 3,268 (0%) | 0% | 20.4 | 9,172 | Ords 0.31p |
| Biomarin pharma Inc - Registered Shares | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,720 | 27,800 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 13,162 | 68,671 (0%) | 0% | - | Common Stock | |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.50 per share. | 12 Apr 2024 | 22 | 2,818 (0%) | 0% | 20.5 | 451 | Ords 0.31p |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.95 per share. | 20 Mar 2024 | 438 | 2,796 (0%) | 0% | 21.0 | 9,177 | Ords 0.31p |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.06 per share. | 12 Jan 2024 | 16 | 2,358 (0%) | 0% | 20.1 | 321 | Ords 0.31p |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 5,200 | 15,825 (0%) | 0% | 0 | Common Stock | |
| Biomarin pharma Inc - Registered Shares | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 4,190 | 23,080 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 13,192 | 55,509 (0%) | 0% | - | Common Stock | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 5,200 | 10,625 (0%) | 0% | 0 | Common Stock | |
| Biomarin pharma Inc - Registered Shares | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 4,980 | 18,890 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 14,645 | 42,317 (0%) | 0% | - | Common Stock | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 12,659 | 12,659 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 3,617 | 5,425 (0%) | 0% | 0 | Common Stock | |
| Biomarin pharma Inc - Registered Shares | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 5,120 | 13,910 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 7,558 | 27,672 (0%) | 0% | - | Common Stock |